NeuroPace Inc
Company Profile
Business description
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.
Contact
455 N. Bernardo Avenue
Mountain ViewCA94043
USAT: +1 650 237-2700
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
209
Stocks News & Analysis
stocks
Hostile takeover on the cards for this ASX income opportunity
stocks
Get ready for major US tech earnings starting tomorrow morning
stocks
Corning’s AI fiber boom is real, but its stock price may be getting out of hand
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,915.70 | 16.00 | 0.18% |
| CAC 40 | 8,059.76 | 44.33 | -0.55% |
| DAX 40 | 23,990.90 | 27.36 | -0.11% |
| Dow JONES (US) | 49,141.93 | 25.86 | -0.05% |
| FTSE 100 | 10,251.93 | 80.86 | -0.78% |
| HKSE | 26,111.84 | 432.06 | 1.68% |
| NASDAQ | 24,663.80 | 223.30 | -0.90% |
| Nikkei 225 | 59,917.46 | 619.90 | -1.02% |
| NZX 50 Index | 12,770.30 | 5.90 | 0.05% |
| S&P 500 | 7,138.80 | 35.11 | -0.49% |
| S&P/ASX 200 | 8,687.00 | 9.40 | 0.11% |
| SSE Composite Index | 4,107.51 | 28.88 | 0.71% |